-
Safety, efficacy and patient-reported outcomes 6 years after fidanacogene elaparvovec in adults with hemophilia B. Blood Adv. 2026 Feb 24. Samelson-Jones BJ, Rasko JE, Ducore J, McGuinn C, George LA, von Mackensen S, Borgonuovo G, Agathon D, Smith L, Wilcox LJ, Biondo F, Plonski F. PMID: 41734390.
-
Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk. N Engl J Med. 2025 Oct 02; 393(13):1269-1278. Smith-Bindman R, Alber SA, Kwan ML, Pequeno P, Bolch WE, Bowles EJA, Greenlee RT, Stout NK, Weinmann S, Moy LM, Stewart C, Francisco M, Kofler C, Duncan JR, Ducore J, Mahendra M, Pole JD, Miglioretti DL. PMID: 40961449; PMCID: PMC12445590.
-
Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study. N Engl J Med. 2025 Apr 17; 392(15):1508-1517. Rasko JEJ, Samelson-Jones BJ, George LA, Giermasz A, Ducore JM, Teitel JM, McGuinn CE, High KA, de Jong YP, Chhabra A, O'Brien A, Smith LM, Winburn I, Rupon J. PMID: 40239068.
-
Correction: Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review. Drugs R D. 2025 Mar; 25(1):89-98. Reding MT, Lalezari S, Kenet G, Di Minno G, Ducore J, Solms A, Shah A, Holme PA, Poulsen LH, Meijer K, Simpson M, Mancuso ME. PMID: 39702563; PMCID: PMC12011687.
-
Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review. Drugs R D. 2024 Sep; 24(3):359-381. Reding MT, Lalezari S, Kenet G, Di Minno G, Ducore J, Solms A, Shah A, Holme PA, Poulsen LH, Meijer K, Simpson M, Mancuso ME. PMID: 39162954; PMCID: PMC11456056.
-
Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12-<18 Years at Enrolment into PROTECT VIII. Acta Haematol. 2025; 148(1):58-67. Reding MT, Simpson M, Ducore J, Holme PA, Maas Enriquez M, Mancuso ME. PMID: 38599195; PMCID: PMC11809454.
-
Medical imaging utilization and associated radiation exposure in children with down syndrome. PLoS One. 2023; 18(9):e0289957. Marlow EC, Ducore JM, Kwan ML, Bowles EJA, Greenlee RT, Pole JD, Rahm AK, Stout NK, Weinmann S, Smith-Bindman R, Miglioretti DL. PMID: 37672503; PMCID: PMC10482278.
-
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study. Eur J Haematol. 2023 Oct; 111(4):544-552. Mathias M, Abraham A, Belletrutti MJ, Carcao M, Carvalho M, Chambost H, Chan AKC, Dubey L, Ducore J, Gattens M, Gresele P, Gruel Y, Guillet B, Jiménez-Yuste V, Kitanovski L, Klukowska A, Lohade S, Mancuso ME, Oldenburg J, Pollio B, Sigaud M, Vilchevska K, Wu JKM, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ. PMID: 37439123.
-
Long-term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients. Haemophilia. 2023 Jul; 29(4):1005-1012. Mathias M, Abashidze M, Abraham A, Belletrutti MJ, Carcao M, Chambost H, Chan AKC, Dubey L, Ducore J, Lambert T, Kavardakova N, Lohade S, Turea V, Wu JKM, Klukowska A. PMID: 37335546.
-
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Haemophilia. 2022 Jul; 28(4):548-556. Pipe SW, Hermans C, Chitlur M, Carcao M, Castaman G, Davis JA, Ducore J, Dunn AL, Escobar M, Journeycake J, Khan O, Mahlangu J, Meeks SL, Mitha IH, Négrier C, Nowak-Göttl U, Recht M, Chrisentery-Singleton T, Stasyshyn O, Vilchevska KV, Martinez LV, Wang M, Windyga J, Young G, Alexander WA, Bonzo D, Macie C, Mitchell IS, Sauty E, Wilkinson TA, Shapiro AD. PMID: 35475308; PMCID: PMC9542908.
-
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors. Haemophilia. 2021 Nov; 27(6):921-931. Escobar M, Castaman G, Boix SB, Callaghan M, de Moerloose P, Ducore J, Hermans C, Journeycake J, Leissinger C, Luck J, Mahlangu J, Miesbach W, Mitha IH, Négrier C, Quon D, Recht M, Schved JF, Shapiro AD, Sidonio R, Srivastava A, Stasyshyn O, Vilchevska KV, Wang M, Young G, Alexander WA, Al-Sabbagh A, Bonzo D, Macie C, Wilkinson TA, Kessler C. PMID: 34636112; PMCID: PMC9292935.
-
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors. Haemophilia. 2021 Nov; 27(6):911-920. Escobar M, Luck J, Averianov Y, Ducore J, Fernández MFL, Giermasz A, Hart DP, Journeycake J, Kessler C, Leissinger C, Mahlangu J, Martinez LV, Miesbach W, Mitha IH, Quon D, Reding MT, Schved JF, Stasyshyn O, Vilchevska KV, Wang M, Windyga J, Alexander WA, Al-Sabbagh A, Bonzo D, Mitchell IS, Wilkinson TA, Hermans C. PMID: 34614267; PMCID: PMC9292306.
-
Assessing Safe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia. J Pediatr Hematol Oncol. 2021 08 01; 43(6):e880-e885. Huschart E, Ducore J, Chung J. PMID: 33625079.
-
Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A. Haemophilia. 2021 Jul; 27(4):e559-e562. Santagostino E, Lalezari S, Reding MT, Ducore J, Ng HJ, Poulsen LH, Michaels LA, Linardi C. PMID: 33939226.
-
Leukemia Risk in a Cohort of 3.9 Million Children with and without Down Syndrome. J Pediatr. 2021 Jul; 234:172-180.e3. Marlow EC, Ducore J, Kwan ML, Cheng SY, Bowles EJA, Greenlee RT, Pole JD, Rahm AK, Stout NK, Weinmann S, Smith-Bindman R, Miglioretti DL. PMID: 33684394; PMCID: PMC8238875.
-
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study. Thromb Haemost. 2021 Nov; 121(11):1400-1408. Liesner RJ, Abraham A, Altisent C, Belletrutti MJ, Carcao M, Carvalho M, Chambost H, Chan AKC, Dubey L, Ducore J, Gattens M, Gresele P, Gruel Y, Guillet B, Jimenez-Yuste V, Kitanovski L, Klukowska A, Lohade S, Mancuso ME, Oldenburg J, Pavlova A, Pollio B, Sigaud M, Vdovin V, Vilchevska K, Wu JKM, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ. PMID: 33581698; PMCID: PMC8570909.
-
Modelling future usage and cost of factor and emicizumab to treat haemophilia A for the US Western States Region IX haemophilia treatment centres. Haemophilia. 2021 Jan; 27(1):e22-e29. Stonebraker JS, Ducore JM. PMID: 33012106.
-
Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial. Thromb Res. 2019 Nov; 183:13-19. Santagostino E, Lalezari S, Reding MT, Ducore J, Ng HJ, Poulsen LH, Michaels LA, Linardi CCG. PMID: 31513978.
-
A novel approach to immune tolerance induction in haemophilia A with factor VIII inhibitor. Haemophilia. 2019 01; 25(1):e48-e50. Thornburg CD, Ducore J. PMID: 30468284.
-
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant. N Engl J Med. 2017 12 07; 377(23):2215-2227. George LA, Sullivan SK, Giermasz A, Rasko JEJ, Samelson-Jones BJ, Ducore J, Cuker A, Sullivan LM, Majumdar S, Teitel J, McGuinn CE, Ragni MV, Luk AY, Hui D, Wright JF, Chen Y, Liu Y, Wachtel K, Winters A, Tiefenbacher S, Arruda VR, van der Loo JCM, Zelenaia O, Takefman D, Carr ME, Couto LB, Anguela XM, High KA. PMID: 29211678; PMCID: PMC6029626.
-
Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors. Haemophilia. 2017 Nov; 23(6):844-851. Ducore J, Lawrence JB, Simpson M, Boggio L, Bellon A, Burggraaf J, Stevens J, Moerland M, Frieling J, Reijers J, Wang M. PMID: 28984010.
-
Primary Renal Lymphoma Presenting as End-Stage Renal Disease. Case Rep Med. 2017; 2017:9210648. Butani L, Ducore J. PMID: 29098007; PMCID: PMC5642876.
-
Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study. Haemophilia. 2018 Mar; 24(2):211-220. Liesner RJ, Abashidze M, Aleinikova O, Altisent C, Belletrutti MJ, Borel-Derlon A, Carcao M, Chambost H, Chan AKC, Dubey L, Ducore J, Fouzia NA, Gattens M, Gruel Y, Guillet B, Kavardakova N, El Khorassani M, Klukowska A, Lambert T, Lohade S, Sigaud M, Turea V, Wu JKM, Vdovin V, Pavlova A, Jansen M, Belyanskaya L, Walter O, Knaub S, Neufeld EJ. PMID: 28815880.
-
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding. Haemophilia. 2017 Nov; 23(6):832-843. Wang M, Lawrence JB, Quon DV, Ducore J, Simpson ML, Boggio LN, Mitchell IS, Yuan G, Alexander WA, Schved JF. PMID: 28776894.
-
End-Stage Renal Disease From Cast Nephropathy in a Teenager With Neuroendocrine Carcinoma. J Pediatr Hematol Oncol. 2016 07; 38(5):e177-9. Butani L, Ducore J. PMID: 26989910.
-
Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thromb Haemost. 2016 07 04; 116(1):42-9. Buckner TW, Leavitt AD, Ragni M, Kempton CL, Eyster ME, Cuker A, Lentz SR, Ducore J, Leissinger C, Wang M, Key NS. PMID: 27009484.
-
Dust metal loadings and the risk of childhood acute lymphoblastic leukemia. J Expo Sci Environ Epidemiol. 2015 Nov-Dec; 25(6):593-8. Whitehead TP, Ward MH, Colt JS, Dahl G, Ducore J, Reinier K, Gunier RB, Katharine Hammond S, Rappaport SM, Metayer C. PMID: 25736162; PMCID: PMC4560677.
-
Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B. Expert Rev Hematol. 2014 Oct; 7(5):559-71. Ducore JM, Miguelino MG, Powell JS. PMID: 25142322.
-
WARM N COLD: malignant and benign renal tumors in children. Emerg Radiol. 2014 Jun; 21(3):261-9. Sanchez TR, Ducore J, Balagtas J, Molloy C, Wootton-Gorges SL. PMID: 24570120.
-
Children and adolescents with ALL are taller than expected at diagnosis. J Pediatr Hematol Oncol. 2014 Jan; 36(1):16-21. Huang T, Ducore JM. PMID: 23799523.
-
Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1600-11. Metayer C, Zhang L, Wiemels JL, Wiemels JL, Bartley K, Schiffman J, Ma X, Aldrich MC, Chang JS, Selvin S, Fu CH, Ducore J, Smith MT, Buffler PA. PMID: 23853208; PMCID: PMC3769478.
-
Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model. Int J Oncol. 2013 Feb; 42(2):741-8. Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM. PMID: 23232667; PMCID: PMC3583839.
-
Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice. Int J Oncol. 2012 Dec; 41(6):2207-12. Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM. PMID: 23041950; PMCID: PMC3583654.
-
Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model. Int J Oncol. 2012 Apr; 40(4):1277-84. Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM. PMID: 22200740; PMCID: PMC3270126.
-
Thrombotic thrombocytopenic purpura in a child with systemic lupus erythematosus. J Pediatr Hematol Oncol. 2011 Apr; 33(3):221-3. Thampi S, Salmi D, Imashuku S, Ducore J, Satake N. PMID: 21336165.
-
Parthenolide treatment activates stress signaling proteins in high-risk acute lymphoblastic leukemia cells with chromosomal translocation t(4;11). Int J Oncol. 2010 Nov; 37(5):1307-13. Zunino SJ, Storms DH, Ducore JM. PMID: 20878078.
-
Diagnostic X-rays and risk of childhood leukaemia. Int J Epidemiol. 2010 Dec; 39(6):1628-37. Bartley K, Metayer C, Selvin S, Ducore J, Buffler P. PMID: 20889538; PMCID: PMC2992630.
-
Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11). Cancer Lett. 2010 Oct 01; 296(1):49-54. Zunino SJ, Storms DH, Ducore JM. PMID: 20381955; PMCID: PMC2906616.
-
Bleeding symptoms and laboratory correlation in patients with severe von Willebrand disease. Haemophilia. 2009 Jul; 15(4):918-25. Metjian AD, Wang C, Sood SL, Cuker A, Peterson SM, Soucie JM, Konkle BA, HTCN Study Investigators. PMID: 19473418.
-
Risk factors for the development of obesity in children surviving ALL and NHL. J Pediatr Hematol Oncol. 2009 Feb; 31(2):101-7. Gofman I, Ducore J. PMID: 19194192.
-
Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells. Cancer Lett. 2007 Aug 28; 254(1):119-27. Zunino SJ, Ducore JM, Storms DH. PMID: 17470383.
-
Rhabdomyoblastic pulmonary lesions in a patient with Wilms tumor: choristomas or metastases? Pediatr Blood Cancer. 2006 Mar; 46(3):381-4. Zwerdling T, Ducore J, Taylor D, West DC, Konia T. PMID: 15926167.
-
Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296. Pediatr Blood Cancer. 2006 Feb; 46(2):179-86. Winter SS, Holdsworth MT, Devidas M, Raisch DW, Chauvenet A, Ravindranath Y, Ducore JM, Amylon MD. PMID: 16007607.
-
Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia. Br J Cancer. 2005 Aug 08; 93(3):379-84. Kwan ML, Buffler PA, Wiemels JL, Metayer C, Selvin S, Ducore JM, Block G. PMID: 16052219; PMCID: PMC2361562.
-
Cancer occurrence in Southeast Asian children in California. J Pediatr Hematol Oncol. 2004 Oct; 26(10):613-8. Ducore JM, Parikh-Patel A, Gold EB. PMID: 15454830.
-
Cancer Occurrence in Southeast Asian Children in California. J Pediatr Hematol Oncol. 2004 Oct; 26(10):613-618. Ducore JM, Parikh-Patel A, Gold EB. PMID: 27811600.
-
The North American Immune Tolerance Registry: practices, outcomes, outcome predictors. Thromb Haemost. 2002 Jan; 87(1):52-7. DiMichele DM, Kroner BL, North American Immune Tolerance Study Group. PMID: 11848456.
-
Surveillance neuroimaging to detect relapse in childhood brain tumors: a Pediatric Oncology Group study. J Clin Oncol. 2001 Nov 01; 19(21):4135-40. Minn AY, Pollock BH, Garzarella L, Dahl GV, Kun LE, Ducore JM, Shibata A, Kepner J, Fisher PG. PMID: 11689581.
-
Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis. Arch Dis Child. 2000 Nov; 83(5):439-42. Gospe SM, Caruso RD, Clegg MS, Keen CL, Pimstone NR, Ducore JM, Gettner SS, Kreutzer RA. PMID: 11040156; PMCID: PMC1718535.
-
Oral methotrexate for recurrent brain tumors in children: a Pediatric Oncology Group study. J Pediatr Hematol Oncol. 2000 Jan-Feb; 22(1):41-4. Mulne AF, Ducore JM, Elterman RD, Friedman HS, Krischer JP, Kun LE, Shuster JJ, Kadota RP. PMID: 10695820.
-
Bone marrow transplant in thalassemia. A role for radiation? Ann N Y Acad Sci. 1998 Jun 30; 850:503-5. Lee YS, Kristovich KM, Ducore JM, Vichinsky E, Crouse VL, Glader BE, Amylon MD. PMID: 9668596.
-
Hydrogen peroxide induces DNA single strand breaks in respiratory epithelial cells. Inflammation. 1993 Dec; 17(6):715-22. McDonald RJ, Pan LC, St George JA, Hyde DM, Ducore JM. PMID: 8112830.
-
Air bags: trade-offs. N Engl J Med. 1991 Nov 21; 325(21):1518-9. Rosenblatt M, Freilich B, Kirsch D. PMID: 1944435.
-
A DNA crosslinking drug alters synthesis of several low molecular weight proteins in human lymphoma cells. Biochem Biophys Res Commun. 1991 Apr 30; 176(2):717-21. Widstrom RL, Ducore JM. PMID: 2025284.
-
High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1991 Apr; 9(4):572-80. Ravindranath Y, Steuber CP, Krischer J, Civin CI, Ducore J, Vega R, Pitel P, Inoue S, Bleher E, Sexauer C, et al. PMID: 2066754.
-
Bone pain as an initial symptom of childhood acute lymphoblastic leukemia: association with nearly normal hematologic indexes. J Pediatr. 1990 Aug; 117(2 Pt 1):233-7. Jonsson OG, Sartain P, Ducore JM, Buchanan GR. PMID: 2380822.
-
Relationship between life expectancy and endogenous DNA single-strand breakage, strand break induction and DNA repair capacity in the adult housefly, Musca domestica. Mech Ageing Dev. 1989 Sep; 49(3):259-70. Newton RK, Ducore JM, Sohal RS. PMID: 2682059.
-
DNA-protein crosslinking in normal and solar UV-sensitive ICR 2A frog cell lines exposed to solar UV-radiation. Mutat Res. 1989 May; 217(3):219-26. Rosenstein BS, Lai LW, Ducore JM, Rosenstein RB. PMID: 2716758.
-
Effect of age on endogenous DNA single-strand breakage, strand break induction and repair in the adult housefly, Musca domestica. Mutat Res. 1989 Mar; 219(2):113-20. Newton RK, Ducore JM, Sohal RS. PMID: 2927416.
-
Cytotoxicity and DNA damage caused by the azoxy metabolites of procarbazine in L1210 tumor cells. Cancer Res. 1989 Jan 01; 49(1):127-33. Erikson JM, Tweedie DJ, Ducore JM, Prough RA. PMID: 2908840.
-
Medically inappropriate hospital use in a pediatric population. N Engl J Med. 1988 Oct 06; 319(14):953. PMID: 3419464.
-
EDTA alkaline elution characteristics and measurement of DNA damage in unlabeled DNA using Hoechst 33258 fluorescence. Environ Mol Mutagen. 1988; 11(4):449-60. Ducore JM. PMID: 2453357.
-
alpha-Difluoromethylornithine effects on nitrosourea-induced cytotoxicity and crosslinking in a methylation excision repair positive (MER+) human cell line. Biochem Pharmacol. 1987 Jul 01; 36(13):2169-74. Ducore JM. PMID: 3111477.
-
DNA-protein crosslinking in normal human skin fibroblasts exposed to solar ultraviolet wavelengths. Photochem Photobiol. 1987 Jul; 46(1):143-6. Lai LW, Ducore JM, Rosenstein BS. PMID: 3615631.
-
Effect of alpha-difluoromethylornithine on L-phenylalanine mustard-induced cytotoxicity and DNA interstrand cross-linking in a human cell line in vitro. Cancer Res. 1986 Mar; 46(3):1068-72. Ducore JM, McNamara L. PMID: 3080230.
-
cis-Diamminedichloroplatinum(II) (DDP)-induced crosslinking and crosslink removal in L1210 cells in vitro after theophylline co-treatment. Biochem Pharmacol. 1986 Feb 15; 35(4):607-11. Ducore JM. PMID: 3947390.
-
The use of metabolic inhibitors to compare the excision repair of pyrimidine dimers and nondimer DNA damages in human skin fibroblasts exposed to 254-nm and sunlamp-produced greater than 310-nm ultraviolet radiation. Environ Mutagen. 1986; 8(3):335-43. Rosenstein BS, Chao CC, Ducore JM. PMID: 3709422.
-
Use of a highly sensitive assay to analyze the excision repair of dimer and nondimer DNA damages induced in human skin fibroblasts by 254-nm and solar ultraviolet radiation. Cancer Res. 1985 Nov; 45(11 Pt 1):5526-31. Rosenstein BS, Murphy JT, Ducore JM. PMID: 4053026.
-
Analysis of the excision repair of nondimer DNA damage induced by solar ultraviolet radiation in ICR 2A frog cells. Radiat Res. 1985 Aug; 103(2):286-92. Rosenstein BS, Chao CC, Ducore JM. PMID: 3875117.
-
Theophylline release of replicon initiation inhibition by nitrosoureas correlates with the synergistic killing in L1210 leukemia in vitro. Mutat Res. 1985 Jul; 146(1):1-8. Ducore JM, Rosenstein BS. PMID: 4000148.
-
Theophylline reversal of alkylator-induced replicon initiation inhibition: no correlation with DDP-induced cytotoxicity. Mutat Res. 1984 Oct; 141(2):117-21. Ducore JM, Rosenstein BS. PMID: 6541756.
-
Theophylline does not reverse DNA replicon initiation inhibition in human cells resistant to alkylating agent-theophylline killing synergism. Chem Biol Interact. 1984 Sep 15; 51(2):191-200. Ducore JM, Rosenstein BS. PMID: 6540627.
-
Enhancement by bilirubin of DNA damage induced in human cells exposed to phototherapy light. Pediatr Res. 1984 Jan; 18(1):3-6. Rosenstein BS, Ducore JM. PMID: 6701032.
-
Quantitative cell survival from growth curves following anti-neoplastic drug treatment. Mutat Res. 1983 Dec; 122(3-4):391-6. Ducore JM, Barth E. PMID: 6686284.
-
The mechanism of bilirubin-photosensitized DNA strand breakage in human cells exposed to phototherapy light. Mutat Res. 1983 Dec; 112(6):397-406. Rosenstein BS, Ducore JM, Cummings SW. PMID: 6656800.
-
Acute psychosis complicating induction therapy for acute lymphoblastic leukemia. J Pediatr. 1983 Sep; 103(3):477-80. Ducore JM, Waller DA, Emslie G, Bertolone SJ. PMID: 6577167.
-
Induction of DNA strand breaks in normal human fibroblasts exposed to monochromatic ultraviolet and visible wavelengths in the 240-546 nm range. Photochem Photobiol. 1983 Jul; 38(1):51-5. Rosenstein BS, Ducore JM. PMID: 6622552.
-
Effects of the epipodophyllotoxin VP-16-213 on cell cycle traverse, DNA synthesis, and DNA strand size in cultures of human leukemic lymphoblasts. Cancer Res. 1983 Apr; 43(4):1592-7. Kalwinsky DK, Look AT, Ducore J, Fridland A. PMID: 6572554.
-
Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. Cancer Res. 1982 Mar; 42(3):897-902. Ducore JM, Erickson LC, Zwelling LA, Laurent G, Kohn KW. PMID: 7199380.
-
Differential cytotoxicity and DNA cross-linking in normal and transformed human fibroblasts treated with cis-diamminedichloroplatinum(II). Cancer Res. 1981 Jul; 41(7):2791-4. Erickson LC, Zwelling LA, Ducore JM, Sharkey NA, Kohn KW. PMID: 7195771.
-
Regression on oxymetholone-induced hepatic tumors after bone marrow transplantation in aplastic anemia. Transplantation. 1980 Aug; 30(2):90-6. Montgomery RR, Ducore JM, Githens JH, August CS, Johnson ML. PMID: 7010713.
-
DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas. Proc Natl Acad Sci U S A. 1980 Jan; 77(1):467-71. Erickson LC, Bradley MO, Ducore JM, Ewig RA, Kohn KW. PMID: 6928639; PMCID: PMC348292.
-
Multiple leukemic clones in acute leukemia of childhood. Hum Genet. 1978 Feb 16; 40(3):269-78. Morse HG, Ducore JM, Hays T, Peakman D, Robinson A. PMID: 273006.
-
Letter: Thyroid carcinoma. N Engl J Med. 1976 Aug 05; 295(6):340-2. PMID: 934215.
US